Aarkstore Enterprise---ev3 Inc. (evvv) - Financial And Strategic Analysis Review

Share:    

ev3 Inc. (ev3) is a global medical device company engaged in developing innovative

technologies and solutions for the endovascular treatment of peripheral vascular and neurovascular diseases. The company principally operates in the US, Canada, Europe and other countries. It offers a wide range of treatment options, including primary interventional technologies such as plaque excision systems, stents, peripheral angioplasty balloons, liquid embolics, embolic protection devices, embolization coils, thrombectomy catheters, flow diversion and occlusion balloons. It is headquartered in Minnesota, the US

ev3 Inc. Key Recent Developments

Apr 29, 2010: ev3 Reports Net Income Of $9.8 Million In Q1 2010

Apr 08, 2010: MEDRAD Signs Supply Agreement With ev3 For Definitive AR Pilot Study

Apr 08, 2010: Medrad Signs Supply Agreement With ev3 For Definitive AR Pilot Trial

Feb 18, 2010: ev3 Reports Net Income Of $41.9 Million In 2009

Jan 06, 2010: ev3 Completes Voluntary Recall Of TrailBlazer Support Catheter

This comprehensive SWOT analysis of ev3 Inc. provides you an in-depth strategic analysis of the companys businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including,

- Business description A detailed description of the companys operations and business divisions.

- Corporate strategy Analysts summarization of the companys business strategy.

- SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.

- Company history Progression of key events associated with the company.

- Major products and services A list of major products, services and brands of the company.

- Key competitors A list of key competitors to the company.

- Key employees A list of the key executives of the company.

- Executive biographies A brief summary of the executives employment history.

- Key operational heads A list of personnel heading key departments/functions.

- Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.

For more information please contact :

http://www.aarkstore.com/reports/ev3-Inc-EVVV-Financial-and-Strategic-Analysis-Review-62723.html

http://blogs.aarkstore.com/

From:Aarkstore Enterprise

Contact: Neel

Email: press@aarkstore.com

URL: www.aarkstore.com

by: Aarkstore Enterprise

POST COMMENT

Aarkstore Enterprise---william Demant Holding A/s (wdh) - Financial And Strategic Analysis Review Aarkstore Enterprise---eli Lilly And Company (lly) - Financial And Strategic Analysis Review Aarkstore Enterprise---cerner Corporation (cern) - Financial And Strategic Analysis Review Aarkstore Enterprise---cochlear Limited (coh) - Financial And Strategic Analysis Review Aarkstore Enterprise---isoft Group Limited (isf) - Financial And Strategic Analysis Review Aarkstore Enterprise---genzyme Corporation (genz) - Financial And Strategic Analysis Review Aarkstore Enterprise---angiodynamics, Inc. (ango) - Financial And Strategic Analysis Review Aarkstore Enterprise---daxor Corporation (dxr) - Financial And Strategic Analysis Review Aarkstore Enterprise---icad, Inc. (icad) - Financial And Strategic Analysis Review Aarkstore Enterprise---cryolife, Inc. (cry) - Financial And Strategic Analysis Review Aarkstore Enterprise---immucell Corporation (iccc) - Financial And Strategic Analysis Review Aarkstore Enterprise---abaxis, Inc. (abax) - Financial And Strategic Analysis Review Aarkstore Enterprise---masimo Corporation (masi) - Financial And Strategic Analysis Review